Eccogene is a clinical stage biopharmaceutical company developing best-in-class small molecule therapeutics for cardiometabolic and inflammatory conditions
Eccogene is a clinical stage biopharmaceutical company developing best-in-class small molecule therapeutics for cardiometabolic and inflammatory conditions. The company focuses on discovering safer and more effective oral therapies that can be used alone or synergistically with GLP-1 receptor agonists to treat conditions beyond weight management.